NEW YORK, Oct. 13 (GenomeWeb News) - Applera said today that it has filed a complaint in California Superior Court, county of San Mateo, relating to disputes with Hoffman-La Roche and some of its subsidiaries over PCR technology.
Applera also said that that, in a separate action involving Roche, it has filed a notice of arbitration with the American Arbitration Association.
"Rights to PCR are part of the intellectual property estate of Applera," Applied Biosystems president Michael Hunkapiller said in a statement. "With these actions, Applera is seeking to protect its rights to PCR and obtain fair value from these rights."
Applera has licenses from Roche to certain PCR intellectual property, and markets TaqMan products that use Roche-designed PCR technology.
An Applera spokeswoman declined to comment on the matter. Officials from Roche were unavailable.